Akagera Medicines Receives $7.8 Million Grant Expansion to Advance Dendritic Cell-Targeted mRNA Tuberculosis Vaccine Toward First-in-Human Trial - Yahoo Finance
1fuente
1país
1idioma
09:00detectada el 18/11 (15:00 UTC)
09:00última novedad, 18/11
1noticia
Cadena de publicación
La publicó primero Yahoo Finance (Sudáfrica) el 18/11 a las 09:00 (15:00 UTC).
-
09:0018/11, 15:00 UTC
YFYahoo Finance finance.yahoo.comAkagera Medicines Receives $7.8 Million Grant Expansion to Advance Dendritic Cell-Targeted mRNA Tuberculosis Vaccine Toward First-in-Human Trial - Yahoo Finance
ZA EN Primera
Datos de esta historia: JSON

